Welcome to the University of Pittsburgh Wei Du Research Laboratory
Lab Photos

UPMC Hillman Cancer Center

Research Overview

Blood Podcast

University of Pittsburgh
The laboratory of Dr. Wei Du integrates multi-disciplinary approaches spanning molecular biology, DNA damage repair, stem cell biology, in vivo model, to study the underlying mechanisms by which regulate normal and abnormal hematopoiesis, with the special focus on the pathophysiology of hematologic diseases such as bone marrow (BM) failure and leukemia. For our latest news: LinkedIn.
Dr. Du was appointed to the ASH Scientific Committee on Hematopoiesis with a 4 year term. Read here.
Dr. Du received two new awards from NIH. Two postdoc positions are open. Apply here or send CV to wed41@pitt.edu for consideration.
CLRA funded us to study a novel strategy of targeting Stem cell-niche interaction for pediatirc leukemia therapy. Read the full story here
Our article has been featured in Season 6, Episode 18 on Thursday, November 2nd and Listen to the Podcast. here.
Our recent study entitled "LepR+ niche cell-derived AREG compromises HSC maintenance under conditions of DNA repair deficiency and aging" has been published in Blood. Read the paper here & here .
Emily Wolff and Anthony Zhu recently joined the lab. Both of them are fresh Pitt gradutes. They will be great additions to the lab to study underying mechanims regulating hematopoiesis and HSC regeneration under stress conditions.
Our JCI paper focusing on HSC regeration is now available at JCI. In the study, we identified the paracrine Wnt5a/Prox1 signalign axis as a regulator of HSC regeneration under conditions of injury and aging. Read the paper here.
In this Haematologica paper, we investigated the role of TREM1 in hematologic malignancies and uncover previously unknown expression and function of TREM1 in malignant stem cells, and identify TREM1 as a driver of leukemogenesis. Read the paper here.